Cutaneous cryptococosis: systemic or localized disease?

Authors

  • Marilia Kanebley Instituto de Infectologia Emilio Ribas, - São Paulo - SP - Brasil.
  • Marcos Vinicius da Silva Faculdade de Ciências Médicas e da Saúde da PUC-SP - Sorocaba - SP - Brasil.

DOI:

https://doi.org/10.5935/2764-734X.e20230324

Keywords:

Cryptococcosis, Invasive Fungal Infections, Cutaneous Manifestations., Case Report

Abstract

Cutaneous cryptococcosis is a fungal infection that can manifest as localized or disseminated disease in both immunocompetent and immunocompromised patients. The present report describes a case of an 81-year-old man from the rural area of Bahia, with the cutaneous form of the disease. Initially the patient was considered to have primary cryptococcosis and was treated with fluconazole. However, in order to rule out disseminated disease, the patient underwent chest tomography, which showed pulmonary nodules that, associated with positive antigenemia, justified the change to liposomal amphotericin B. There was a satisfactory clinical response with no evident complications related to the treatment, but a late metastatic prostate cancer diagnosis allowed to question the supposed fungal infection spread. The differentiation between localized and disseminated cryptococcosis is difficult, but it is fundamental for the proper direction of treatment.

References

1. Christanson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol J. 2003 Jun;41(3):177-88.

2. Du L, Yang Y, Gu J, Chen J, Liao W, Zhu Y. Systemic review of published reports on primary cutaneous cryptococcosis in immunocompetent patients. Mycopathologia. 2015 Aug;180(1-2):19-25.

3. Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kusuhara M, Ihn H. Cutaneous cryptococcosis. Med Mycol J. 2019;60(4):101-7.

4. Marques SA, Bastazini Junior I, Martins AL, Barreto JA, Barbieri D’Elia MP, Lastória JC, et al. Primary cutaneous cryptococcosis in Brazil: report of 11 cases in immunocompetent and immunosuppressed patients. Int J Dermatol. 2012 Jul;51(7):780-4.

5. Ng WF, Loo KT. Cutaneous cryptococcosis – primary versus secondary disease: report of two cases and review of the literature. Am J Dermatopathol. 1993 Aug;15(4):372-7.

6. Tabassum S, Rahman A, Herekar F, Masood S. Cryptococcal meningitis with secondary cutaneous involvement in an immunocompetent host. J Infect Dev Ctries. 2013 Sep;7(9):680-5.

7. Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS: report of 12 cases and review of the literature. Arch Dermatol. 1996 May;132(5):545-8.

8. Pema K, Diaz J, Guerra LG, Nabhan D, Verghese A. Disseminated cryptococcosis: comparison of clinical manifestations in the pre-AIDS and AIDS era. Arch Intern Med. 1994 May;154(9):1032-4.

9. Amaral DM, Rocha RC, Carneiro LE, Vasconcelos DM, Abreu MA. Disseminated cryptococcosis manifested as a single tumor in an immunocompetent patient, similar to the cutaneous primary forms. An Bras Dermatol. 2016 Sep/Oct;91(5 Suppl 1):S29-S31.

10. Mayers DL, Martone WJ, Mandell GL. Cutaneous cryptococcosis mimicking gram-positive cellulitis in a renal transplant patient. South Med J. 1981 Aug;74(8):1032-3.

11. Lima AM, Rodrigues MM, Reis CMS. Cutaneous cryptococcosis mimicking leishmaniasis. Am J Trop Med Hyg. 2018 Jan;98(1):3-4.

12. Moretti ML, Resende MR, Lazéra MS, Colombo AL, Shikanai-Yasuda MA. Consenso em criptococose-2008. Rev Soc Bras Med Trop. 2008;41(5):524-44.

13. Miller Junior WT, Edelman JM, Miller WT. Cryptococcal pulmonary infections in patients with AIDS: radiographic appearance. Radiology. 1990 Jun;175(3):725-8.

14. Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133-50.

15. Limper AH. The changing spectrum of fungal infections in pulmonary and critical care practice: clinical approach to diagnosis. Proc Am Thorac Soc. 2010;7:163-8.

16. Swinne D, De Vroey C. Detection of circulating capsular polysaccharide antigenfrom Cryptococcus neoformans. J Clin Microbiol. 1992 Sep;30(9):2521.

17. Hafner C, Linde HJ, Vogt T, Breindl G, Tintelnot K, Koellner K, et al. Primary cutaneous cryptococcosis and secondary antigenemia in a patient with long-term corticosteroid therapy. Infection. 2005 Apr;33(2):86-9.

18. Nunez M, Peacock Junior JE, Chin Junior R. Pulmonary cryptococcosis in the immunocompetent host: therapy with oral fluconazole: a report of four cases and a review of the literature. Chest. 2000 Aug;118(2):527-34.

19. Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis. 2003 Feb;36(3):337-47.

20. Yamaguchi H, Komase Y, Ikehara M, Yamamoto T, Shinagawa T. Disseminated cryptococcal infection with eosinophilia in a healthy person. J Infect Chemother. 2008 Aug;14(4):319-24.

Downloads

Published

2023-05-31

How to Cite

Kanebley, M., & Silva, M. V. da. (2023). Cutaneous cryptococosis: systemic or localized disease?. Infections in Evidence, 2, e20230324. https://doi.org/10.5935/2764-734X.e20230324

Issue

Vol. 2 (2023)

Section

Case Reports

License

Copyright (c) 2023 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.